Neutrogena Oil-Free Acne Stress Control Power Clear Scrub

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of acne. It is effective in managing acne even before it emerges, providing proactive care for individuals at risk of developing this condition.

There are no teratogenic effects associated with this drug, nor are there any nonteratogenic effects noted.

Dosage and Administration

Healthcare professionals are advised to instruct patients to cleanse their face daily as part of their skincare regimen. The patient should begin by wetting the face with water. Following this, the scrub should be applied by gently massaging it onto the face, taking care to avoid contact with the delicate eye area. It is essential to rinse the face thoroughly after application to ensure complete removal of the product.

Contraindications

Use is contraindicated in the following situations:

• The product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is required.

• Contact with eyes must be avoided. If exposure occurs, it is essential to flush the eyes thoroughly with water.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In cases where irritation is observed, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

It is imperative to avoid contact with the eyes. Should contact occur, patients must be instructed to flush the eyes thoroughly with water to prevent potential damage.

Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware that it is for external use only. The most common adverse reactions reported include skin irritation and dryness, particularly when used concurrently with other topical acne medications. To minimize the risk of irritation, it is advised that patients use only one topical acne medication at a time.

In the event of contact with the eyes, patients should flush thoroughly with water to alleviate any potential discomfort. Additionally, if the product is swallowed, it is imperative to seek medical assistance or contact a Poison Control Center immediately. These precautions are essential to ensure the safe use of the product and to mitigate any adverse effects.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Neutrogena Oil-Free Acne Stress Control Power Clear Scrub (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been specifically studied in pregnant patients, and no explicit warnings or precautions regarding its use during pregnancy are provided in the prescribing information. There are no stated safety concerns, dosage modifications, or special precautions related to the use of this product in pregnant individuals. Additionally, no contraindications in pregnancy are mentioned. Healthcare professionals should consider the absence of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants from the use of this product during lactation.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

When using this product, it is important to inform patients that skin irritation and dryness may be more likely to occur if they are using another topical acne medication concurrently. Therefore, if irritation develops, patients should be instructed to use only one topical acne medication at a time to minimize the risk of adverse effects.

Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes. Instruct patients that if contact occurs, they should flush the eyes thoroughly with water to reduce the risk of irritation or injury.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure optimal conditions are met throughout the storage period.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients regarding the potential for increased skin sensitivity to sunlight due to the presence of an alpha hydroxy acid (AHA) in the formulation. Patients are advised to use sunscreen, wear protective clothing, and limit sun exposure while using the product and for one week following its use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Neutrogena Oil-Free Acne Stress Control Power Clear Scrub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)